← Open Payments lookup

AMY SIMPSON-WAID: Open Payments

NPI 1710209184 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,584 in 92 payments from 20 companies in 2025. Trend: 2023 $1,578 · 2024 $1,311 · 2025 $1,584

Food & beverage: $1,584
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$169
Amgen Inc.10$162
Lilly USA, LLC10$150
GlaxoSmithKline, LLC.13$141
Sumitomo Pharma America, Inc.7$122
Abbott Laboratories6$105
Novo Nordisk Inc5$98
Corcept Therapeutics4$76
Merck Sharp & Dohme LLC3$66

Products named: CAPLYTA, MOUNJARO, GEMTESA, EVENITY, FREESTYLE LIBRE, FARXIGA, Ozempic, SHINGRIX.

Industry payments across MS — which companies pay providers there.